Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range. Continue Reading »

Now that all adults in the US are eligible to receive a COVID-19 vaccine, we encourage everyone, especially people with diabetes or obesity, to get the vaccine as soon as they can. Plus, what does the data show about vaccination so far in the diabetes community? Continue Reading »

New results on Eylea, a treatment for diabetes-related retinopathy, show that the therapy reduces the risk of more serious eye complications when used for prevention. Continue Reading »

How do our brains and bodies motivate us to eat? What makes us eat past the point of hunger? And how we can develop healthier eating habits? Continue Reading »

Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.  Continue Reading »

Diabetes increases the risk of severe COVID-19 illness, but does the relationship between diabetes and the virus go in the other direction? Scientists are now studying whether infection with COVID-19 could cause someone to develop diabetes. Continue Reading »

Insulet’s Omnipod 5 automated insulin delivery system was shown to be effective, safe, and easy to use for adults, teens, and children with type 1 diabetes. Early results from a very small group also show Omnipod 5 to be particularly helpful for people with type 2 diabetes. ​ Continue Reading »

GMI provides an estimated A1C level based on continuous glucose monitoring data and can avoid some of the limitations of A1C tests. A recent study compared actual A1C levels with GMI to see how the two compared in the real world. Continue Reading »

Pages